XBiotech Inc.
XBIT
$3.50
$0.0551.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 927.00K | 777.00K | 1.98M | 1.03M | 783.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.75M | 7.90M | 14.97M | 10.85M | 8.59M |
| Operating Income | -8.75M | -7.90M | -14.97M | -10.85M | -8.59M |
| Income Before Tax | -10.55M | -5.01M | -13.03M | -9.98M | -4.73M |
| Income Tax Expenses | -41.00K | 9.00K | -25.00K | 25.00K | -99.00K |
| Earnings from Continuing Operations | -10.51M | -5.02M | -13.01M | -10.00M | -4.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.51M | -5.02M | -13.01M | -10.00M | -4.64M |
| EBIT | -8.75M | -7.90M | -14.97M | -10.85M | -8.59M |
| EBITDA | -8.31M | -7.47M | -14.53M | -10.42M | -8.15M |
| EPS Basic | -0.34 | -0.16 | -0.43 | -0.33 | -0.15 |
| Normalized Basic EPS | -0.22 | -0.10 | -0.27 | -0.20 | -0.10 |
| EPS Diluted | -0.34 | -0.16 | -0.43 | -0.33 | -0.16 |
| Normalized Diluted EPS | -0.22 | -0.10 | -0.27 | -0.20 | -0.10 |
| Average Basic Shares Outstanding | 30.47M | 30.47M | 30.46M | 30.44M | 30.44M |
| Average Diluted Shares Outstanding | 30.47M | 30.47M | 30.46M | 30.44M | 30.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
